 |
 |
|||
         |
2010 Santa Fe Bone Symposium: |
 |
|
|
Request for Industry Support11th Santa Fe Bone SymposiumAugust 6-7, 2010
Description: The Santa Fe Bone Symposium is an annual forum for the informal exchange of scientific, social, and economic information on osteoporosis, metabolic bone disease, and assessment of skeletal health. In-depth dialogue between faculty and participants is emphasized. Presented by: The Osteoporosis Foundation of New Mexico (OFNM), a not-for-profit 501(c)3 corporation dedicated to the support of osteoporosis education and research. Associated educational activities: The symposium is expected to be immediately preceded by the Research Symposium in Metabolic Bone Disease and Osteoporosis Update for Endocrine Fellows, sponsored by The Endocrine Society under the direction of Drs. Michael McClung and John Bilezikian. Planning and logistics for this program are in progess. CME: 10.0 credit hours in Category 1 of the Physician’s Recognition Award of the American Medical Association are being requested from the Greater Albuquerque Medical Association. ISCD Recertification Credit: 10.0 hours toward ISCD recertification. Enduring educational material: As in recent past years, a manuscript based on symposium presentations will be prepared and submitted for publication in a peer-reviewed scientific journal. Symposium registration fee: $195 advance, $225 late, $250 on-site Location: Eldorado Hotel, Santa Fe, New Mexico. Needs assessment: Osteoporosis is a topic of increasing interest for healthcare professionals. The Santa Fe Bone Symposium has a proven track record as a popular annual CME event for participants and speakers. Program evaluations show that the majority of attendees plan on returning for future symposia. All suggestions for program changes and topics for the future are carefully considered in the planning for topics and speakers for the following year. The selection of speakers, topics, and format for 2010 were based on the needs assessment and outcome measures from 2009, with consideration of new publications in peer-reviewed journals and presentations at recent scientific meetings. Dates: Friday and Saturday, August 6-7, 2010 Program Director: E. Michael Lewiecki, MD 2010 Confirmed Symposium Faculty: Sundeep Khosla, MD; Nelson Watts, MD; John Bilezikian, MD; Robert Marcus, MD; Paul Miller, MD; Didier Hans, PhD. 2010 Program: Topics will include emerging concepts and new therapeutic agents in the management of osteoporosis, controversies with bisphosphonate therapies, clinical implications of age-related changes in bone structure, insights into novel potential uses of PTH, challenges in laboratory testing for the management of osteoporosis, report on the 2010 ISCD/IOF initiative “Interpretation and Use of FRAX in Clinical Practice,” emerging clinical applications of peripheral BMD measuring technologies, oral presentations of scientific abstracts, challenging case presentations, panel discussion of hot topics in osteoporosis, and sessions for DXA technologists on quality BMD testing. Expected participants: Meeting space accommodates 150-200, depending on seating arrangements. Registration is limited to 200 in order to maintain the tradition of high faculty to participant ratio. Participants consist of physician “thought-leaders” (clinicians, educators, researchers) with special interest and knowledge about osteoporosis, primary care providers, nurse practitioners and DXA technologists. In 2009, about 75% of registered participants came from outside New Mexico, with some from outside the US. Social events: Sponsorship opportunities are available to host a wine and cheese welcome reception for all meeting participants on the evening of Friday, August 6, 2010; an intimate Meet-the-Faculty dinner following the reception; and a private pre-opera dinner reception for faculty and dignitaries on Saturday, August 7, 2010. The Santa Fe Opera and many other cultural events are taking place on the meeting days. Santa Fe: This historic town in northern New Mexico is capitol of the state. It is home to one of the largest art markets in the world, with over 200 galleries within walking distance. There are numerous shops, museums, and historical sites to enjoy, as well as many fine restaurants. The Eldorado Hotel is just one block from
History of the Santa Fe Bone Symposium: 2000. The first Santa Fe Bone Symposium was held on Saturday, August 5, 2000, at The Bishop’s Lodge in Santa Fe, New Mexico. The faculty consisted of John Bilezikian, MD; Mike Lewiecki, MD; Paul Miller, MD; and Nelson Watts, MD. There were 66 participants and 10 exhibitors. Presentations included “Monitoring of Treatment for the New Millennium” (Dr. Watts), “Progress and Controversy in Osteoporosis Reporting” (Dr. Miller), “Hot New Treatment Strategies for Osteoporosis” (Dr. Bilezikian), and “Blazing New Trails in the Management of Vertebral Fractures” (Dr. Lewiecki). There was a faculty debate on several controversial topics, with a special appearance by Leon Lenchick, MD. There were 30 registered for the ISCD bone densitometry course, which was limited to physicians only. 2001. The second Santa Fe Bone Symposium, held on August 4, 2001, was moved to the Eldorado Hotel, near the Santa Fe Plaza, to allow participants and guests easier access to Santa Fe activities. Guest faculty included Nelson Watts, MD, who spoke on combination therapy and gave an update on ISCD activities; Mike McClung, MD, talking on bisphosphonate therapy and controversies in bone densitometry; Mary Bouxsein, PhD, speaking on the biomechanics of fractures; and Jane Cauley, DrPH, who addressed the relationship between osteoporosis and other diseases. There were 131 registered participants and 15 exhibitors. Mike Maricic, MD, and Oscar Gluck, MD, participated on the expert panel for challenging case presentations. Most participants indicated that they plan on returning next year, and voted on the program evaluation form to expand the symposium to 1½ days. The ISCD bone densitometry course had 80 physicians and technologists registered. 2002. The Santa Fe Bone Symposium was expanded to 1½ days (9 hours CME credit) at the request of previous attendees. Faculty included Cliff Rosen, MD; Dennis Black, PhD; Mike Maricic, MD; Leon Lenchik, MD; Deborah Grady, MD, MPH; and Paul Miller, MD. Once again there were over 100 attendees and many exhibitors representing pharmaceutical companies, device manufacturers, and bone marker products. The ISCD bone densitometry course had about 80 attendees. 2003. The symposium faculty consisted of Larry Riggs, MD; David Dempster, PhD; Laura Bachrach, MD; and Ken Saag, MD; with Paul Miller, MD, as special guest moderator. Highlighted topics were bone quality, bone densitometry and management of low BMD in children, osteoporosis in men, anabolic and antiresorptive therapy, and estrogen therapy in the post-WHI era. There were 135 attendees, 20 exhibitors, many industry guests, and 76 students at the ISCD Bone Densitometry Course. 2004. Speakers were Larry Raisz, MD; Steve Cummings, MD; Bess Dawson-Hughes, MD; Steve Petak, MD; and Paul Miller, MD. Topics included pathogenesis of osteoporosis, lessons for clinical practice from large prospective clinical studies, medico-legal issues in the management of osteoporosis, nutritional aspects of bone health, secondary causes of osteoporosis, antiresorptive therapy, and anabolic therapy. 2005. Speakers for 2005 were Harry Genant, MD; Robert Lindsay, MD; David Kendler, MD; Sydney Bonnick, MD; Michael Maricic, MD; and Michael Lewiecki, MD. Presentations covered estrogen and skeletal health, evaluation of osteoporosis, vertebral fracture assessment, ISCD Official Positions, fracture risk reporting, PTH and bisphosphonate therapy for osteoporosis, imaging of bone microarchitecture, and more. The luncheon satellite symposium on adherence to therapy was very well attended. 2006. Felicia Cosman, MD; Nancy Lane, MD; Mike Kleerekoper, MD; Neil Binkley, MD; Paul Miller, MD; and Mike McClung, MD gave presentations at the 2006 symposium. Topics were diverse in nature, with state-of-the-art topics and updates on many clinically relevant issues. Enduring educational material with highlights of the Santa Fe Bone Symposium was published in a peer-reviewed medical journal: Lewiecki EM. Proceedings of the Santa Fe Bone Symposium 2006. Women’s Health. 2006;2(6):825-828. 2007. Faculty were Cyrus Cooper, MA, DM; John Bilezikian, MD; Marc Hochberg, MD; Marjorey Luckey, MD; Paul Miller, MD; and Mike Lewiecki, MD. Topics included new agents in development for the treatment of osteoporosis, new paradigms fracture risk assessment, evaluation for secondary causes of osteoporosis, epidemiology of osteoporosis, nonvertebral fracture risk reduction, osteonecrosis of the jaw, new ISCD Official Positions for adults and children, and osteomalacia. There were several lively interactive sessions with extensive audience participation. For the first time, a sponsored scientific exhibit called “real life experience in osteoporosis” was held. Also for the first time, two meetings for endocrinology fellows were held in association with the Santa Fe Bone Symposium- a research symposium in metabolic bone disease and osteoporosis update, under the direction of Drs. Steve Harris and John Bilezikian. Enduring educational material in the form of a review authored by all speakers was published in a peer-reviewed medical journal: Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clin Densitom. 2008;11(2):313-324. 2008. Symposium faculty were Richard Eastell, MD; John Bilezikian, MD; Paul Miller, MD; Sandy Baim, MD, Meryl LeBoff, MD. Presentations included an update on the development of new therapeutic agents for the treatment of osteoporosis; management of skeletal health with aromatase inhibitor therapy; combination therapy with anabolic and antiresorptive drugs; injectable bisphosphonate therapy; new guidelines for bone density testing; new guidelines for prevention and treatment of osteoporosis; skeletal health assessment with technologies other than central DXA; monitoring osteoporosis therapy; osteoporosis in men; clinical application of bone turnover markers; low BMD in premenopausal women; and more. Enduring educational material in the form of a review authored by all speakers was published in a peer-reviewed medical journal: Lewiecki EM, Baim S, Bilezikian JP, Eastell R, LeBoff MS, Miller PD. 2008 Santa Fe Bone Symposium: update on osteoporosis. J Clin Densitom. 2009;12(2):135-157. 2009. The 10th Anniversary Santa Fe Bone Symposium faculty consisted of Graham Russell, MD; Robert Recker, MD; Michael Whyte, MD; Andrew Laster, MD; Paul Miller, MD; and John Bilezikian, MD. Topics included emerging concepts and new therapeutic agents in the management of osteoporosis, heritable disorders of RANKL/RANK/OPG signaling, bone histomorphometry for clinicians, bisphosphonate mechanism of action, renal bone disease, socio-economics of osteoporosis care, update on activities of the NOF and ISCD, challenging case presentations, and panel discussion of hot topics in osteoporosis. Practical insights from the 2009 Santa Fe Bone Symposium, an online CME enduring material activity with audiovisual presentations, has been developed and is available at http://2009santafebonesymposium.com/, accessed November 23, 2009. Proceedings of the symposium have been written by the faculty and submitted for publication.
Summary of Santa Fe Bone Symposium enduring medical education materials Lewiecki EM. Proceedings of the Santa Fe Bone Symposium 2006. Women’s Health. 2006;2(6):825-828. Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clin Densitom. 2008;11(2):313-324. Lewiecki EM, Baim S, Bilezikian JP, Eastell R, LeBoff MS, Miller PD. 2008 Santa Fe Bone Symposium: update on osteoporosis. J Clin Densitom. 2009;12(2):135-157. Practical insights from the 2009 Santa Fe Bone Symposium, an online CME enduring material activity with audiovisual presentations, available at http://2009santafebonesymposium.com/, accessed November 23, 2009. Lewiecki EM, Bilezikian JP, Laster AJ, Miller PD, Recker RR, Russell RGG, Whyte MP. 2009 Santa Fe Bone Symposium. Submitted for consideration for publication in a peer-reviewed medical journal. Symposium Sponsorship Levels Diamond- $50,000 or more Gold- $25,000 to $49,999
Other Sponsorship Opportunities Pre-opera Faculty Dinner Reception, Saturday evening, August 7, 2010 Satellite Symposium, Saturday luncheon, August 7, 2010 Enduring medical education material Other arrangements will be considered upon request. Mailing List- The mailing list of registrants will be provided free of charge to diamond and platinum symposium sponsors, and to all sponsors of special events. There is a charge of $100 for all others who wish to obtain the mailing list in advance to the symposium. Yvonne Brusuelas – Symposium Coordinator Tel. 505-855-5627
For Meeting Planning Information, Contact: For Clinical Information, Contact: Tel. 505-855-5525 Online Registration (available after 2/15/10 at www.ofnm.org)
Page last updated: 01/11/2010
Osteoporosis Foundation of New Mexico 300 Oak Street, NE, Albuquerque, NM 87106 Phone: 505-855-5627 - Fax: 505-884-4006
|
|
|||
|
||||
